The HYMADE consortium will meet the 12th and 13th of March at CIC biomaGUNE to officially launch the project.

The project entitled Hybrid Drug Delivery Systems upon Mesoporous Materials, Self Assembled Therapeutics and Virosomes aims at developing controlled release systems based on porous materials, polymers and virus particles, and assess their possible application in the treatment for cancer and chronic diseases like rheumatoid arthritis and uveitis.
As the materials used are porous; the drugs can be inserted and are released gradually by modifying the surface of the porous particles by means of polymers and virus particles. This enables a better control of the release and the direction of the materials. The project, coordinated by researcher Sergio Moya, is a global approach to the study of these systems based on their synthesis, physical and chemical characterisation, modelling, and in-vitro and invivo studies.

The project involves the exchange of professionals and will give PhD students the chance to carry out placements outside Europe.
In order to meet its goals, HYMADE is working with eight bodies, four of which are European, and will have a multi-disciplinary team of leading scientists in the fields of materials science, chemistry, physics and biophysics, from Germany, Austria, France, Spain, US,